MENU
+Compare
TMDX
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$131.45
Change
+$1.39 (+1.07%)
Capitalization
2.4B

TMDX TransMedics Group Forecast, Technical & Fundamental Analysis

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states... Show more

TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TMDX with price predictions
Jun 27, 2025

TMDX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for TMDX moved above the 200-day moving average on June 05, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 54 cases where TMDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 303 cases where TMDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TMDX moved out of overbought territory on June 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TMDX as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TMDX turned negative on June 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TMDX broke above its upper Bollinger Band on June 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TMDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.513) is normal, around the industry mean (24.307). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (9.881) is also within normal values, averaging (42.612).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TMDX is expected to report earnings to fall 36.39% to 44 cents per share on July 31

TransMedics Group TMDX Stock Earnings Reports
Q2'25
Est.
$0.45
Q1'25
Beat
by $0.44
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.14
The last earnings report on May 08 showed earnings per share of 69 cents, beating the estimate of 25 cents. With 623.72K shares outstanding, the current market capitalization sits at 2.40B.
A.I. Advisor
published General Information

General Information

a developer of a proprietary system for preserving human organs for transplant

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
200 Minuteman Road
Phone
+1 978 552-0900
Employees
584
Web
https://www.transmedics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMOJX9.800.11
+1.14%
MassMutual Overseas Y
FGTAX28.110.21
+0.75%
Fidelity Advisor Mega Cap Stock A
CWICX70.410.38
+0.54%
American Funds Capital World Gr&Inc 529C
ABCRX22.590.11
+0.49%
American Beacon The London Co Inc Eq R6
OCMAX21.80-0.83
-3.67%
OCM Gold Atlas

TMDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with RDNT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then RDNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMDX
1D Price
Change %
TMDX100%
+1.07%
RDNT - TMDX
37%
Loosely correlated
-1.60%
ALGN - TMDX
33%
Poorly correlated
+0.42%
SMTI - TMDX
32%
Poorly correlated
+0.18%
NVST - TMDX
32%
Poorly correlated
+0.10%
GKOS - TMDX
32%
Poorly correlated
+0.36%
More